鄰近類別 類別統計 近3年內發表的文件:6(100.00%) 含全文筆數:6(100.00%) 文件下載次數統計 下載大於0次:6(100.00%) 下載大於100次:3(50.00%) 檔案下載總次數:593(100.00%) 最後更新時間: 2024-12-01 18:36 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Higher tumor mutational burden is a... Proteomic profiling of tumor microe... Terminal deoxynucleotidyl transfera... Low-dose computed tomography screen... Low-dose computed tomography screen... Regulation of dendritic cell matura...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-6 / 6. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2024-09	Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma	Pediatric Blood and Cancer. 2024 Sep;71(9):Article number e31176.
2024-05	Proteomic profiling of tumor microenvironment and prognosis risk prediction in stage I lung adenocarcinoma	Lung Cancer. 2024 May;191:Article number 107791.
2024-04	Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia	Pathology Research and Practice. 2024 Apr;256:Article number 155287.
2023-11-01	Low-dose computed tomography screening in relatives with a family history of lung cancer	Journal of Thoracic Oncology. 2023 Nov 1;18(11):1492-1503.
2023-11	Low-dose computed tomography screening in relatives with a family history of lung cancer	Journal of Thoracic Oncology. 2023 Nov;18(11):1492-1503.
2023-09	Regulation of dendritic cell maturation in osimertinib-treated lung adenocarcinoma patients	Journal of the Formosan Medical Association. 2023 Sep;122(9):955-960.

顯示項目1-6 / 6. (共1頁) 1  每頁顯示[10|25|50]項目